Importance of real-time assays to distinguish multidrug efflux pump-inhibiting and outer membrane-destabilizing activities in Escherichia coli

Journal of Bacteriology

Volumn 197, Issue 15, 2015, Pages 2479-2488

  Misra, Rajeev ^a   Morrison, Keith D ^b   Cho, Hyun Jae ^a   Khuu, Thanh ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRAB PROTEIN; ACREF PROTEIN; CHLORAMPHENICOL; ERYTHROMYCIN; ESCHERICHIA COLI PROTEIN; NALIDIXIC ACID; NITROCEFIN; OUTER MEMBRANE PROTEIN; PHENYLALANYLARGININE BETA NAPHTHYLAMIDE; POLYMYXIN B NONAPEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN INHIBITOR; TOLC PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CARRIER PROTEIN; DIPEPTIDE; PHENYLALANYLARGININE-NAPHTHYLAMIDE; POLYMYXIN B;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL STRAIN; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; DRUG POTENTIATION; ESCHERICHIA COLI; FLUORESCENCE; GENE INSERTION SEQUENCE; HYDROLYSIS; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OUTER MEMBRANE; OUTER MEMBRANE DESTABILIZATION; PERMEABILITY BARRIER; PRIORITY JOURNAL; REAL TIME EFFLUX ASSAY; ANALOGS AND DERIVATIVES; ANIMAL; CELL MEMBRANE; DRUG EFFECTS; GENE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; PERMEABILITY; PHENOTYPE; PHYSIOLOGY; RABBIT;

ESCHERICHIA COLI;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CELL MEMBRANE; DIPEPTIDES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENES, MDR; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PERMEABILITY; PHENOTYPE; POLYMYXIN B; RABBITS;

EID: 84937010356     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02456-14     Document Type: Article

References (58)

1. Burgess DS, Rapp RP. 2008. Bugs versus drugs: addressing the pharmacist's challenge. Am J Health Syst Pharm 65:S4 -S15. http://dx.doi.org/10.2146/ajhp080075.
2. Fischbach MA, Walsh CT. 2009. Antibiotics for emerging pathogens. Science 325:1089-1093. http://dx.doi.org/10.1126/science.1176667.
3. Nikaido H, Pagès JM. 2012. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36:340-363. http://dx.doi.org/10.1111/j.1574-6976.2011.00290.x.
4. Nishino K, Yamaguchi A. 2001. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol 183:5803-5812. http://dx.doi.org/10.1128/JB.183.20.5803-5812.2001.
5. Piddock LJV. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382-402. http://dx.doi.org/10.1128/CMR.19.2.382-402.2006.
6. Nishino K, Nikaido E, Yamaguchi A. 2009. Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. Biochim Biophys Acta 1794:834-843. http://dx.doi.org/10.1016/j.bbapap .2009.02.002.
7. Misra R, Bavro VN. 2009. Assembly and transport mechanism of tripartite drug efflux systems. Biochim Biophys Acta 1794:817-825. http://dx .doi.org/10.1016/j.bbapap.2009.02.017.
8. Nikaido H. 2011. Structure and mechanism of RND-type multidrug efflux pumps. Adv Enzymol Relat Areas Mol Biol 77:1-60.
9. Pos KM. 2009. Drug transport mechanism of the AcrB efflux pump. Biochim Biophys Acta 1794:782-793. http://dx.doi.org/10.1016/j.bbapap .2008.12.015.
10. Murakami S, Nakashima R, Yamashita E, Matsumoto T, Yamaguchi A. 2006. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443:173-179. http://dx.doi.org /10.1038/nature05076.
11. Seeger MA, Schiefner A, Eicher T, Verrey F, Diederichs K, Pos KM. 2006. Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 313:1295-1298. http://dx.doi.org/10.1126/science .1131542.
12. Sennhauser G, Amstutz P, Briand C, Storchenegger O, Grutter MG. 2007. Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors. PLoS Biol 5:e7. http://dx.doi.org/10.1371/journal.pbio .0050007.
13. Andersen C, Koronakis E, Bokma E, Eswaran J, Humphreys D, Hughes C, Koranakis V. 2002. Transition to the open state of the TolC periplasmic tunnel entrance. Proc Natl Acad Sci U S A 99:11103-11108. http://dx .doi.org/10.1073/pnas.162039399.
14. Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C. 2000. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405:914-919. http://dx.doi.org/10.1038/35016007.
15. Mikolosko JK, Bobyk K, Zgurskaya HI, Ghosh P. 2006. Conformational flexibility in the multidrug efflux system protein AcrA. Structure 14:577-587. http://dx.doi.org/10.1016/j.str.2005.11.015.
16. Bavro VN, Pietras Z, Furnham N, Pérez-Cano L, Fernández-Recio J, Pei XY, Misra R, Luisi B. 2008. Assembly and channel opening in a bacterial drug efflux machine. Mol Cell 30:114-121. http://dx.doi.org/10.1016/j .molcel.2008.02.015.
17. Weeks JW, Bavro VN, Misra R. 2014. Genetic assessment of the role of AcrB β-hairpins in the assembly of the TolC-AcrAB multidrug efflux pump of Escherichia coli. Mol Microbiol 91:965-975. http://dx.doi.org/10.1111/mmi.12508.
18. Weeks JW, Celaya-Kolb T, Pecora S, Misra R. 2010. AcrA suppressor alterations reverse the drug hypersensitivity phenotype of a TolC mutant by inducing TolC aperture opening. Mol Microbiol 75:1468-1483. http://dx.doi.org/10.1111/j.1365-2958.2010.07068.x.
19. Sulavik MC, Houseweart C, Cramer C, Jiwani N, Murgolo N, Greene J, DiDomenico B, Shaw KJ, Miller GH, Hare R, Shimer G. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 45:1126-1136. http://dx .doi.org/10.1128/AAC.45.4.1126-1136.2001.
20. Bohnert JA, Kern WV. 2005. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob Agents Chemother 49:849-852. http://dx.doi .org/10.1128/AAC.49.2.849-852.2005.
21. Lau SY, Zgurskaya HI. 2006. Cell division defects in Escherichia coli deficient in the multidrug efflux transporter AcrEF-TolC. J Bacteriol 187:7815-7825.
22. Olliver A, Vallé M, Chaslus-Dancla E, Cloeckaert A. 2005. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob Agents Chemother 49:289-301. http://dx.doi.org/10.1128/AAC.49.1.289-301.2005.
23. Hirakawa H, Takumi-Kobayashi A, Theisen U, Hirata T, Nishino K, Yamaguchi A. 2008. AcrS/EnvR represses expression of the acrAB multidrug efflux genes in Escherichia coli. J Bacteriol 190:6276-6279. http://dx .doi.org/10.1128/JB.00190-08.
24. Nishino K, Yamaguchi A. 2004. Role of histone-like protein H-NS in multidrug resistance of Escherichia coli. J Bacteriol 186:1423-1429. http://dx.doi.org/10.1128/JB.186.5.1423-1429.2004.
25. Hommais F, Krin E, Laurent-Winter C, Soutourina O, Malpertuny A, Le Caer J, Danchin A, Bertin P. 2001. Large-scale monitoring of pleiotropic regulation of gene expression by the prokaryotic nucleoidassociated protein, H-NS. Mol Microbiol 40:20-36. http://dx.doi.org/10.1046/j.1365-2958.2001.02358.x.
26. Jellen-Ritter AS, Kern WV. 2001. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob Agents Chemother 45:1467-1472. http://dx.doi.org/10.1128/AAC.45.5.1467-1472.2001.
27. Klein JR, Henrich B, Plapp R. 1990. Molecular cloning of the envC gene of Escherichia coli. Curr Microbiol 21:341-347. http://dx.doi.org/10.1007/BF02199435.
28. Kobayashi K, Tsukagoshi N, Aono R. 2001. Suppression of hypersensitivity of Escherichia coli acrB mutant to organic solvents by integrational activation of the acrEF operon with the IS1 or IS2 element. J Bacteriol 183:2646-2653. http://dx.doi.org/10.1128/JB.183.8.2646-2653.2001.
29. Lomovskaya O, Bostian KA. 2006. Practical applications and feasibility of efflux pump inhibitors in the clinic-a vision for applied use. Biochem Pharmacol 71:910-918. http://dx.doi.org/10.1016/j.bcp.2005.12.008.
30. Marquez B. 2005. Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87:1137-1147. http://dx.doi.org/10.1016/j.biochi.2005.04.012.
31. Pagès J-M, Amaral L. 2009. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta 1794:826-833. http://dx.doi.org/10.1016/j.bbapap .2008.12.011.
32. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronka R, Lee M, Blais J, Cho D, Chamberland S, Renau T, Leger R, Hecker S, Watkins W, Hoshino K, Ishida H, Lee VJ. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa:novel agents for combination therapy. Antimicrob Agents Chemother 45:105-116. http://dx.doi.org/10.1128/AAC.45.1.105-116.2001.
33. Iino R, Nishino K, Noji H, Yamaguchi A, Matsumoto Y. 2012. A microfluidic device for simple and rapid evaluation of multidrug efflux pump inhibitors. Front Microbiol 3:40. http://dx.doi.org/10.3389/fmicb .2012.00040.
34. Lamers RP, Cavallari JF, Burrows LL. 2013. The efflux inhibitor phenylalanine arginine-beta-naphthylamide (PAβN) permeabilizes the outer membrane of Gram-negative bacteria. PLoS One 8:e60666. http://dx.doi .org/10.1371/journal.pone.0060666.
35. Matsumoto Y, Hayama K, Sakakihara S, Nishino K, Noji H, Iino R, Yamaguchi A. 2011. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS One 6:e18547. http://dx .doi.org/10.1371/journal.pone.0018547.
36. Amaral L, Engi H, Viveiros M, Molnar J. 2007. Comparison of multidrug resistant efflux pumps of cancer and bacterial cells with respect to the same inhibitory agents. In Vivo 21:237-244.
37. Viveiros M, Jesus A, Brito M, Leandro C, Martins M, Ordway D, Molnar AM, Molnar J, Amaral J. 2005. Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes. Antimicrob Agents Chemother 49:3578 -3582. http://dx.doi.org/10.1128/AAC.49.8.3578-3582.2005.
38. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol Rev 56:395-411.
39. Werner J, Misra R. 2005. YaeT (Omp85) affects the assembly of lipiddependent and lipid independent outer membrane proteins of Escherichia coli. Mol Microbiol 57:1450-1459. http://dx.doi.org/10.1111/j.1365-2958.2005.04775.x.
40. Gerken H, Misra R. 2004. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli. Mol Microbiol 54:620-631. http://dx.doi.org/10.1111/j .1365-2958.2004.04301.x.
41. Bennion D, Charlson ES, Coon E, Misra R. 2010. Dissection of β-barrel outer membrane 472 protein assembly pathways through characterizing BamAPOTRA1 mutants of Escherichia coli. Mol Microbiol 77:1153-1171. http://dx.doi.org/10.1111/j.1365-2958.2010.07280.x.
42. Bohnert JA, Karamian B, Nikaido H. 2010. Optimized Nile Red efflux assay of AcrAB TolC multidrug efflux system shows competition between substrates. Antimicrob Agents Chemother 54:3770-3777. http://dx.doi .org/10.1128/AAC.00620-10.
43. O'Callaghan CH, Morris A, Kirby SM, Shingler AH. 1972. Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1:283-288. http://dx.doi.org /10.1128/AAC.1.4.283.
44. Boliver F, Rodriguez RL, Greene PJ, Betlach MC, Heyneker HL, Boyer HW, Crosa JH, Falkow S. 1977. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2:95-113.
45. Hirai K, Aoyama H, Tsutomu T, Iyobe S, Mitsuhashi S. 1986. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother 29:535-538. http://dx.doi.org/10.1128/AAC.29.3.535.
46. Misra R, Benson SA. 1988. Isolation and characterization of OmpC porin mutants with altered pore properties. J Bacteriol 170:528-533.
47. Misra R, Benson SA. 1988. Genetic identification of the pore domain of the OmpC porin of Escherichia coli K-12. J Bacteriol 170:3611-3617.
48. Takatsuka Y, Chen C, Nikaido H. 2010. Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A 107:6559-6565. http://dx.doi .org/10.1073/pnas.1001460107.
49. Ocaktan A, Yoneyama H, Taiji N. 1997. Use of fluorescence probes to monitor function of the subunit proteins of the MexA-MexB-OprM drug extrusion machinery in Pseudomonas aeruginosa. J Biol Chem 272:21964-21969. http://dx.doi.org/10.1074/jbc.272.35.21964.
50. Seeger MA, Ballmoos CV, Eicher T, Brandstatter L, Verrey F, Diederichs K, Pos KM. 2008. Engineered disulfide bonds support the functional rotation mechanism of multidrug efflux pump AcrB. Nat Struct Mol Microbiol 15:199-2005. http://dx.doi.org/10.1038/nsmb.1379.
51. Träuble H, Overath P. 1973. The structure of Escherichia coli membrane studied by fluorescence measurements of lipid phase transitions. Biochim Biophys Acta 307:491-512. http://dx.doi.org/10.1016/0005-2736(73)90296-4.
52. Bohnert JA, Schuster S, Fähnrich E, Trittler R, Kern WV. 2007. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND type MDR efflux pump YhiV (MdtF). J Antimicrob Chemother 59:1216-1222. http://dx.doi.org/10.1093/jac/dkl426.
53. Nagano K, Nikaido H. 2009. Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A 106:5854-5858. http://dx.doi.org/10.1073/pnas.0901695106.
54. Bohnert JA, Schuster S, Seeger MA, Fähnrich E, Pos KM, Kern WV. 2008. Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrB. J Bacteriol 190:8225-8229. http://dx.doi.org/10.1128/JB.00912-08.
55. Eggert US, Ruiz N, Falcone BV, Branstrom AA, Goldman RC, Silhavy TJ, Kahne D. 2001. Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin. Science 294:361-364. http://dx.doi.org/10.1126/science.1063611.
56. Leonard-Rivera M, Misra R. 2012. Conserved residues of the putative L6 loop of Escherichia coli BamA play a critical role in the assembly of β-barrel outer membrane proteins, including that of BamA itself. J Bacteriol 194:4662-4668. http://dx.doi.org/10.1128/JB.00825-12.
57. Sampson SA, Misra R, Benson SA. 1989. Identification and characterization of a new gene of Escherichia coli K-12 involved in outer membrane permeability. Genetics 122:491-501.
58. Vuong P, Bennion D, Mantei J, Frost D, Misra R. 2008. Analysis of YfgL and YaeT interactions through bioinformatics, mutagenesis, and biochemistry. J Bacteriol 190:1507-1517. http://dx.doi.org/10.1128/JB.01477-07.